Uniphar Group PLC (UPR)

London
Currency in GBP
224.000
-1.000(-0.44%)
Closed
UPR Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
220.000228.180
52 wk Range
163.000248.000
Uniphar Group PLC is currently considered to be UndervaluedExplore our list of undervalued stocks for hidden opportunities
Key Statistics
Edit
Bid/Ask
220.00 / 228.00
Prev. Close
225
Open
228.18
Day's Range
220-228.18
52 wk Range
163-248
Volume
13.09K
Average Volume (3m)
29.87K
1-Year Change
-3.02%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
UPR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low revenue valuation multiple
No news in this category
Looks like there are no results in this news category

Uniphar Group PLC Company Profile

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers. The Pharma division provides high value services across the lifecycle of a pharmaceutical product; and healthcare professionals with access to medicines it cannot source through traditional channels, as well as operates its on demand and pharma service units. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey’s brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, outsourcing and resourcing, telecommunications support, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.

Employees
3000

Compare UPR to Peers and Sector

Metrics to compare
UPR
Peers
Sector
Relationship
P/E Ratio
11.5x22.2x−0.5x
PEG Ratio
0.27−0.660.00
Price/Book
1.8x1.8x2.6x
Price / LTM Sales
0.3x1.0x3.0x
Upside (Analyst Target)
60.4%13.3%53.8%
Fair Value Upside
Unlock15.2%9.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.17%
Dividend Yield
0.72%
Industry Median 2.53%
Annualised payout
1.615
Paid unevenly
5-Years Growth
+21.34%
Growth Streak

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Uniphar (UPR) Stock Price Today?

The Uniphar stock price today is 224.00

What Stock Exchange Does Uniphar Trade On?

Uniphar is listed and trades on the London stock exchange.

What Is the Stock Symbol for Uniphar?

The stock symbol for Uniphar is "UPR."

Does Uniphar Pay Dividends? What’s The Current Dividend Yield?

The Uniphar Group PLC dividend yield is 0.72%.

What Is the Uniphar Market Cap?

As of today, Uniphar market cap is 629.64M.

What is Uniphar Earnings Per Share?

The Uniphar EPS is 0.165.

From a Technical Analysis Perspective, Is UPR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.